Maravai LifeSciences Holdings (MRVI) Institutional Ownership
13F filers reported holding 15.1% of Maravai LifeSciences Holdings (MRVI) shares as of Sep 30, 2026, across 110 filers.
- Held by 13F filers
- 15.1%
- Sep 30, 2026
- 13F filers
- 110
- quarter ended Sep 30, 2026
- 13F value
- $300.7M
- 39.3M shares
- Quarter's fund flow
- Mild accumulation
- 26 new · 11 closed
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Oct 30, 2026 | Asarpota Rajesh | Chief Financial Officer | Disposed · Tax withholding | 5,466 | $8.46 | ↗ |
| Oct 8, 2026 | Brust Bernd | Chief Executive Officer | Disposed · Tax withholding | 29,250 | $7.43 | ↗ |
| Sep 30, 2026 | Asarpota Rajesh | Chief Financial Officer | Disposed · Tax withholding | 5,465 | $7.65 | ↗ |
| Sep 8, 2026 | Brust Bernd | Chief Executive Officer | Disposed · Tax withholding | 29,250 | $7.32 | ↗ |
| Aug 31, 2026 | Asarpota Rajesh | Chief Financial Officer | Disposed · Tax withholding | 5,465 | $7.68 | ↗ |
| Aug 10, 2026 | Brust Bernd | Chief Executive Officer | Disposed · Tax withholding | 29,250 | $6.23 | ↗ |
| Jul 30, 2026 | Asarpota Rajesh | Chief Financial Officer | Disposed · Tax withholding | 5,465 | $6.59 | ↗ |
| Jul 8, 2026 | Brust Bernd | Chief Executive Officer | Disposed · Tax withholding | 29,250 | $5.92 | ↗ |
| Jun 30, 2026 | Asarpota Rajesh | Chief Financial Officer | Disposed · Tax withholding | 65,584 | $6.39 | ↗ |
| Jun 10, 2026 | ORESHACK KURT | General Counsel | Disposed · Open-market sale | 25,000 | $5.10 | ↗ |
| Jun 9, 2026 | ORESHACK KURT | General Counsel | Disposed · Open-market sale | 25,000 | $5.06 | ↗ |
| Jun 9, 2026 | LUCIER GREGORY T | director | Disposed · Gift | 46,293 | — | ↗ |
| Jun 9, 2026 | LUCIER GREGORY T | director | Acquired · Gift | 46,293 | — | ↗ |
| Jun 8, 2026 | Brust Bernd | Chief Executive Officer | Disposed · Tax withholding | 351,001 | $5.02 | ↗ |
| May 26, 2026 | GRAY SUSANNAH | director | Acquired · Grant / award | 46,293 | — | ↗ |
| May 26, 2026 | MARKER LUKE JOSEPH | director | Acquired · Grant / award | 46,293 | — | ↗ |
| May 26, 2026 | CUNNINGHAM SEAN LAURENCE | director | Acquired · Grant / award | 46,293 | — | ↗ |
| May 26, 2026 | DeFord John A | director | Acquired · Grant / award | 46,293 | — | ↗ |
| May 26, 2026 | MIHAS CONSTANTINE S | director | Acquired · Grant / award | 46,293 | — | ↗ |
| May 26, 2026 | LUCIER GREGORY T | director | Acquired · Grant / award | 46,293 | — | ↗ |
* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Maravai LifeSciences Holdings do institutions hold?
13F filers reported holding 15.1% of Maravai LifeSciences Holdings' shares as of Sep 30, 2026, across 110 filers.
How many 13F filers hold Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings was held by 110 13F filers as of Sep 30, 2026.
Not investment advice.

